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Abstract In Alzheimer’s disease, L-amyloid peptides (LA1ÿ40
and LA1ÿ42) are deposited on the brain cell surfaces as
neurotoxic plaques. Some reports indicate that small heat shock
proteins, Hsp27 and KB-crystallin, colocalize in the plaques, but
their functions are not known. Interaction between LA and KB-
crystallin must be determined in order to understand the role of
KB-crystallin in LA fibril formation. We used a pyrene (Pyr)-
labeled LA1ÿ40 in a fluorescence energy transfer experiment.
Upon incubation together at 37‡C, energy transfer between Trp
of KB-crystallin and Pyr of Pyr-labeled LA was observed,
indicating that LA participated in subunit exchange of KB-
crystallin, which promoted fibril formation. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
In Alzheimer’s disease (AD), the plaque around the brain
cell surface contains mainly aggregated L-amyloid (LA) and is
responsible for neurotoxicity [1,2]. The LA peptides 1^40 and
1^42 sequences are the proteolytic degraded products of the
amyloid precursor protein. Some reports indicate that the
small heat shock proteins Hsp27 and KB-crystallin colocalize
in the plaques [3^6]. KB-Crystallin is one of two components
of lens K-crystallin, the other being KA-crystallin. While KA-
crystallin is more or less lens speci¢c, KB-crystallin is widely
expressed in other tissues and its expression increases with
neurodegenerative diseases [7,8]. The role of KB-crystallin in
the development of these diseases is largely unknown but may
be related to its functional role as a small heat shock protein
[9,10]. Recently, K-crystallin was reported to act as a chaper-
one molecule capable of protecting other proteins from dena-
turation [11,12]. Whether this chaperone function is active in
vivo either in the lens or in other tissues is unknown. To
understand the e¡ect of KB-crystallin on LA ¢bril formation,
we need to determine whether they interact to each other. In
the present study, we used £uorescence energy transfer for this
purpose. A pyrene derivative dye was labeled to LA to serve
as an acceptor, while Trp in KB-crystallin served as a donor.
The results indicated that there was an interaction between LA
and KB-crystallin when they were incubated together. A pos-
sible mechanism for this interaction and its implicated signi¢-
cance in vivo were discussed.
2. Materials and methods
2.1. Materials
Human lens recombinant KB-crystallin was prepared as described
elsewhere [13]. LA peptides (LA1ÿ40 and LA1ÿ42) were purchased from
AnaSpec (San Jose, CA, USA). Fluorescence probes thio£avin T
(ThT) and 1-pyrenebutanoic acid succinimidyl ester (Pyr) were ob-
tained from Sigma (St Louis, MO, USA) and Molecular Probes (Eu-
gene, OR, USA), respectively.
Monomer LA was prepared by dissolving LA in 50 mM phosphate
bu¡er, pH 7.4. LA1ÿ40 is soluble, and a fresh sample is in a monomer
state; LA1ÿ42 is apparently in an aggregate state. At the same con-
centrations and measuring conditions, ThT £uorescence is much
greater for LA1ÿ42 than for LA1ÿ40 (Fig. 1). Mild sonication of LA
solutions decreased ThT £uorescence for LA1ÿ42 but not for LA1ÿ40.
For convenience and easy handling, only LA1ÿ40 was used in the
present study. KB-Crystallin was also dissolved in the same phosphate
bu¡er.
2.2. Fluorescence
Fluorescence was measured with an RF-5301PC Shimadzu spectro-
£uorometer (Shimadzu, Columbia, MD, USA). ThT (O= 26.62 at 416
nm) £uorescence was scanned between 460 and 550 nm with excita-
tion wavelength 450 nm [14,15]. Aliquots (20 Wl) of ThT (30 WM) were
added to 3 ml of protein samples and allowed to sit at room temper-
ature for 15 min before measurement. The titration was continued
until saturation was reached.
Labeling of Pyr to LA was performed by a method described in the
supplier’s production information. To label mainly the terminal
amine, a bu¡er close to neutral pH was used. In brief, 2 mg LA
was dissolved in 1 ml of 0.1 M sodium bicarbonate, pH 7.2; 100 Wl
of Pyr solution (0.5 mg in 0.5 ml DMSO) was added and incubated at
room temperature for 1 h. The reaction was stopped by adding 100 Wl
of fresh 1.5 M hydroxylamine. The conjugated LA was separated from
unconjugated LA in a column of Sephadex G-10. The ratio of labeling
was estimated to be approximately 1 (molar ratio).
Upon excitation at 340 nm, an emission spectrum with three emis-
sion peaks at 370, 390, and 420 nm were observed for Pyr [16]. In the
£uorescence resonance energy transfer experiment, the Trp in the un-
labeled KB-crystallin served as a donor and Pyr in the labeled LA as
an acceptor.
2.3. Far-UV circular dichroism (CD)
CD spectra were measured with an Aviv Circular Dichroism Spec-
trometer (model 60 DS; AVIV, Lakewood, NJ, USA). Five scans
were averaged and smoothed by a polynomial-¢tting program. The
CD intensity was expressed as mdeg.
3. Results
3.1. ThT £uorescence
ThT is widely used in the detection of ¢bril formation of
LA, and ThT £uorescence intensity is correlated with the ag-
gregated state of the protein rich in L-sheet conformation
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[14,15]. Fig. 2A showed the increased ThT £uorescence inten-
sity of LA by the presence of KB-crystallin after incubation for
24 h at 37‡C. The control was the mixture of LA and KB-
crystallin incubated separately.
The increased ThT £uorescence intensity was dependent on
the amount of KB-crystallin in the incubation mixtures (Fig.
2B), in which the concentration of KB-crystallin increased
while the amount of LA was ¢xed. The increase was insignif-
icant with KB-crystallin incubated alone.
3.2. Far-UV CD
The far-UV CD for the individual LA1ÿ40 and KB-crystallin
is shown in Fig. 3A. KB-Crystallin displayed a far-UV CD
characteristic of L-sheet conformation [13]. Non-aggregated
LA was reported to exist mostly in random coil [17,18]. Our
CD shows that the fresh LA1ÿ40 samples existed in random
coil conformation and old samples in L-sheet.
The corresponding CD for the mixture of LA1ÿ40 and KB-
crystallin is shown in Fig. 3B. Similar to ThT £uorescence,
CD intensity was greater for the mixture of LA1ÿ40 and KB-
crystallin incubated together than for mixed substance incu-
bated separately. Fibril formation of LA was accompanied by
conversion of random coil to L-sheet.
3.3. Interaction between LA and KB-crystallin
Fig. 4A shows the Trp £uorescence spectrum for KB-crys-
tallin (Vex at 295 nm) and the Pyr £uorescence spectrum for
labeled LA (Vex at 340 nm). Because of the overlap between
Trp emission and Pyr excitation, energy transfer may occur
between these two probes if there is interaction between KB-
crystallin and LA. Fig. 4B shows the decreased Trp £uores-
cence intensity and increased Pyr £uorescence intensity after
they were incubated up to 48 h at 37‡C. The changes were
time-dependent, but intensity increase was complicated by ag-
gregation-related scattering for samples incubated longer than
24 h. Samples incubated at room temperature or 4‡C did not
exhibit energy transfer.
4. Discussion
The increased ThT £uorescence in LA ¢bril formation was
reported to be due to a conversion of L-sheet conformation
[14]. Our results of increased ThT £uorescence clearly indi-
cated that KB-crystallin promoted the formation of L-sheet in
LA. The conversion of the helical and random structure of LA
to L-sheet structure was also evident by the increased far-UV
CD. A similar study of increased ThT £uorescence has been
reported by Stege et al. [19] ; they also show that KB-crystallin
increases the LA toxicity in the cultured neurons. They suggest
that intermediates during LA ¢brillogenesis, called proto¢bril,
may associate with K-crystallin. The mechanisms of the asso-
ciation, however, are unknown.
One report indicates that Hsp25 and Hsp27, but not K-
crystallin, inhibit in vitro LA1ÿ42 ¢bril formation [20]. A re-
cent report, however, shows that both Hsp25 and K-crystallin
promote LA1ÿ40 ¢bril formation [19]. The latter report also
Fig. 2. A: ThT £uorescence of the mixture of LA1ÿ40 and KB-crystallin. Spectrum 1 is the mixture of separately incubated LA1ÿ40 and KB-crys-
tallin (1:1 ratio) and spectrum 2 is the mixture of LA1ÿ40 and KB-crystallin incubated together at 37‡C for 24 h. Concentrations of LA1ÿ40 and
KB-crystallin are 8 WM and 0.08 mg/ml, respectively. ThT concentration is 2 WM. B: E¡ect of KB-crystallin on the ThT £uorescence intensity
of LA1ÿ40 after incubation at 37‡C for 24 h. Increasing amount of KB-crystallin solution (0.08 mg/ml) was added to 1 ml LA solution (8 WM).
The data were an average of two independent experiments and the di¡erence between them did not exceed 5%.
Fig. 1. ThT £uorescence of freshly prepared LA1ÿ42 and LA1ÿ40
peptides: 1, LA1ÿ42 ; 2, sonicated LA1ÿ42 and 3, fresh LA1ÿ40: Con-
centrations of LA and ThT are 2 and 5 WM, respectively. Excitation
wavelength is 450 nm.
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shows that, rather than ¢brillar, it is non-¢brillar aggregates
that are responsible for the neurotoxicity. Since we do not
have EM data, it is not known whether KB-crystallin pro-
moted LA ¢bril formation in our study. However, increased
ThT £uorescence and far-UV CD clearly indicated increased
L-sheet conformation (Figs. 2 and 3), which in a protein gen-
erally facilitates aggregation and insolubilization. In our study
of human lens HMW K-crystallin aggregates, greater L-sheet
conformation was observed than with LMW K-crystallin [21].
We believe that mechanisms similar to K-crystallin HMW
aggregation may occur between LA and KB-crystallin.
Our £uorescence energy transfer study indicated that there
was an interaction between LA and KB-crystallin. The nature
of the interaction is probably that LA participates in the sub-
unit exchange in the KB-crystallin. The dynamic structure of
K-crystallin was reported ¢rst by van den Oetelaar et al. [22]
and later by many other investigators [23^25]. We have re-
ported subunit exchange in the K-crystallin by £uorescence
energy transfer using a dye-labeled KA-crystallin mutant
W9F as an acceptor and Trp in the wild-type KA-crystallin
as a donor [25]. The results indicate that the dye-labeled sub-
units are in the structure of the wild-type KA-crystallin; the
dye probes in the W9F mutant are su⁄ciently close to Trp
residues in the wild-type KA-crystallin to produce an energy
transfer. The present observation of energy transfer between
the dye-labeled LA and KB-crystallin clearly indicates that LA
participated in subunit exchange. The exchange occurs when
LA aggregates to su⁄ciently large size structures, possibly like
reported intermediate proto¢brils [26].
Although it is not clear how the cytoplasmic KB-crystallin is
expressed or migrated to cell surface and colocalizes with LA
in AD plaques, one study has shown that LA is present in the
human lens and may be involved in cataract formation by
facilitating HMW aggregation of K-crystallin [27].
AD is one of the protein condensation diseases that share
the common phenomenon or etiology of protein aggregation
as a stimulating factor [28]. To understand the mechanisms
that promote or inhibit aggregation is very important in the
Fig. 4. A: Trp £uorescence of KB-crystallin (Vex at 295 nm, 0.11 mg/ml) and Pyr £uorescence of labeled LA1ÿ40 (Vex at 340 nm, 4.5 WM).
B: Fluorescence of the mixture of LA1ÿ40 and KB-crystallin (1:1 mixture, Vex at 295 nm) before (curve 1) and after incubation at 37‡C for 24
and 48 h (curves 2 and 3).
Fig. 3. Far-UV CD of LA1ÿ40 and KB-crystallin. A: CD of individual components: 1 and 2, LA1ÿ40 (46 WM, fresh and old samples); 3, KB-
crystallin (0.17 mg/ml). Cell pathlength is 1 mm. B: CD of mixture of LA1ÿ40 (4 WM) and KB-crystallin (0.04 mg/ml) with 5 mm cell, before
and after incubation (curves 1 and 2) at 37‡C for 24 h.
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study of these diseases. Our study may help in the understand-
ing of the role of KB-crystallin in AD and other neurodegen-
erative diseases.
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